28 Nov Chronic Lymphocytic Leukemia – Case Study
Author: Dr. Jia Li (Lily) Liu, Internal Medicine PGY-2, McGill University
Expert Reviewer: Dr. Gizelle Popradi, MD, Assistant Professor, Department of Medicine, Division of Hematology, McGill University
After completion of this self-assessment module, the learner will be able to:
- Understand how to diagnose Chronic Lymphocytic Leukemia (CLL).
- Describe staging systems for
- Understand the indications for treatment of
- Understand screening recommendations for patients with
- Describe first-line therapies of CLL.
Accreditation: This activity is an Accredited Group Learning Activity (Section 3) as defined by the Maintenance of Certification Program of the Royal College of Physicians and Surgeons of Canada and approved by the Canadian Association of Pathologists (CAP-AC). You may claim a maximum of .25 hours.
The CHS Scientific Planning Committee has planned this case to achieve scientific integrity, objectivity and balance.
Scientific Planning Committee
Dr. Salima Ramdani – Resident Physician, Hematology
Dr. Pallavi Ganguli – Resident Physician, Hematology
Dr. Danyal Ladha – Fellow, Hematology
Dr. Joanne Britto – Clinical Hematologist
Dr. Yan Xu – Clinical Hematologist, Hematology/Thrombosis
Dr. Siraj Mithoowani – Clinical Hematologist at St. Joseph’s Healthcare, Hamilton
Dr. Hassan Sibai – Assistant Professor of Medicine, Faculty of Medicine, University of Toronto and Staff Physician, Division of Medical Hematology & Oncology, Princess Margaret Cancer Centre
Conflict of Interest: SPC and Author None